Summary
- Current Price
- As of today, KNSA price is $76.75, down -1.39% on
- Current Price All-Time High
- KNSA price is currently -7.46% below its historical high of $82.94 set on
- Market Cap
- KNSA current market cap is $6B, up +143.05% over the past 365 days
- PE Ratio
- KNSA current PE ratio is 78.04
- Revenue
- KNSA current annual revenue is $677.56M, up +60.09% year-over-year
- Next Earnings
- The next earnings release for KNSA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kiniksa Pharmaceuticals International, plc |
| Ticker | NASDAQ: KNSA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | kiniksa.com |
| Employees | 366 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $76.75 | |
| Price, 1D Change | -1.39% | |
| $6B | ||
| - | ||
| 78.04 | ||
| 0.21 | ||
| $677.56M | ||
| Revenue, 1Y Change | +60.09% | |
| $0.75 | ||
| EPS, 1Y Change | +223.55% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.75 | ||
| EPS Estimate | $1.16 | N/A |
| EPS Est. Change | +54.93% | N/A |
| $677.56M | ||
| Revenue Estimate | $993.71M | N/A |
| Revenue Est. Change | +46.66% | N/A |
| Current Price | $76.75 | |
| Price Target | $98.50 | - |
| Price Tgt. Change | +28.34% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.21 | -$0.60 | -183.50% | |
| $1.06 | $0.75 | -29.65% | |
| $1.16 | N/A | +54.93% | |
| $1.62 | N/A | +116.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $424.18M | $423.24M | -0.22% | |
| $676.51M | $677.56M | +0.16% | |
| $993.71M | N/A | +46.66% | |
| $1.22B | N/A | +80.25% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $76.75 | |
| $49.68 | ||
| $63.38 | ||
| $51.59 | ||
| $65.87 | ||
| $4.21 | ||
| 0.21 | ||
| $3.30 | ||
| 62.42 | ||
| 39.94% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $677.56M | ||
| $0.75 | ||
| $370.35M | ||
| 54.63% | ||
| $77.22M | ||
| 11.40% | ||
| $59.01M | ||
| 8.71% | ||
| $78.78M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 3.79 | ||
| 3.39 | ||
| - | ||
| 7 | ||
| 19.31 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 78.04 | ||
| 7.12 | ||
| 9.15 | ||
| 53.62 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $567.61M | ||
| $414.07M | ||
| $763.63M | ||
| $527.18M | ||
| $196.03M | ||
| $139.18M | ||
| $9.50M | ||
| $2.99M | ||
| $2.03M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $618.56M | ||
| $293.13M | ||
| $307.22M | ||
| $0.00 | ||
| $1.55M | ||
| $0.00 | ||
| $29.86M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $137.99M | ||
| -$188.99M | ||
| $33.02M | ||
| $1.57M | ||
| $136.42M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Goldman Sachs | → | |
| Wedbush | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| Goldman Sachs | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| Wells Fargo | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
No data
Screeners with KNSA
FAQ
- What is the ticker symbol for Kiniksa Pharmaceuticals International, plc?
- The ticker symbol for Kiniksa Pharmaceuticals International, plc is NASDAQ:KNSA
- Does Kiniksa Pharmaceuticals International, plc pay dividends?
- No, Kiniksa Pharmaceuticals International, plc does not pay dividends
- What sector is Kiniksa Pharmaceuticals International, plc in?
- Kiniksa Pharmaceuticals International, plc is in the Healthcare sector
- What industry is Kiniksa Pharmaceuticals International, plc in?
- Kiniksa Pharmaceuticals International, plc is in the Specialty & Generic Drug Manufacturers industry
- What country is Kiniksa Pharmaceuticals International, plc based in?
- Kiniksa Pharmaceuticals International, plc is headquartered in United Kingdom
- When did Kiniksa Pharmaceuticals International, plc go public?
- Kiniksa Pharmaceuticals International, plc initial public offering (IPO) was on May 24, 2018
- Is Kiniksa Pharmaceuticals International, plc in the S&P 500?
- No, Kiniksa Pharmaceuticals International, plc is not included in the S&P 500 index
- Is Kiniksa Pharmaceuticals International, plc in the NASDAQ 100?
- No, Kiniksa Pharmaceuticals International, plc is not included in the NASDAQ 100 index
- Is Kiniksa Pharmaceuticals International, plc in the Dow Jones?
- No, Kiniksa Pharmaceuticals International, plc is not included in the Dow Jones index
- When was Kiniksa Pharmaceuticals International, plc last earnings report?
- Kiniksa Pharmaceuticals International, plc's most recent earnings report was on July 28, 2026
- When does Kiniksa Pharmaceuticals International, plc report earnings?
- The next expected earnings date for Kiniksa Pharmaceuticals International, plc is October 27, 2026
Data Sources & References
- KNSA Official Website www.kiniksa.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1730430/000110465926019168/0001104659-26-019168-index.htm
- KNSA Profile on Yahoo Finance finance.yahoo.com/quote/KNSA
- KNSA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/knsa